Zheng W, Khurana R, Farahmand S, Wang Y, Zhang Z F, Felix J C
Department of Pathology, Women and Children's Hospital, USC School of Medicine, Los Angeles, California 90033, USA.
Am J Surg Pathol. 1998 Dec;22(12):1463-73. doi: 10.1097/00000478-199812000-00003.
Uterine papillary serous carcinoma (UPSC) is a biologically aggressive carcinoma that causes a disproportionate number of endometrial cancer deaths because of its dismal clinical outcome. Although the precursor lesion of UPSC has been suggested both morphologically and molecularly, diagnosis continues to represent a challenge to surgical pathologists, particularly in biopsy specimens, largely in part because of its multiple histologic patterns and many benign morphologic mimics. In this study, we used p53 immunohistochemical staining as an adjunct test to correctly identify six cases of uterine surface carcinoma (USC) prospectively and three cases retrospectively. Both sensitivity and specificity for this immunostaining method approached 100% when the cutoff score of p53 overexpression was 7 or higher. The precision estimated by receiving operating characteristic curve was 100%, indicating that the diagnostic value of the score for p53 overexpression was very high. p53 immunohistochemical staining was considered a significant adjunct diagnostic method for the probable precursor lesion of UPSC. The probable precursor lesion of UPSC, previously referred to as endometrial intraepithelial carcinoma or endometrial carcinoma in situ, appears to represent the early phase of UPSC. However, unlike its names would suggest, this lesion is often multicentric and behaves in a more aggressive fashion than regular in situ carcinomas. For this reason, we prefer the term uterine surface carcinoma, a term that is more descriptive and less restrictive, to emphasize the unique aggressive nature of the UPSC precursor lesion. The reason we postulate using the term uterine surface carcinoma rather than endometrial intraepithelial carcinoma or endometrial carcinoma in situ is that the latter terms would seem define a neoplastic process confined to the endometrial epithelium without potential for metastasis. In reality, the precursor lesion of UPSC has a tendency to stromal and vascular space involvement as seen by the presence of stromal and vascular invasion in one of the prospectively identified USC cases. Therefore, the term uterine surface carcinoma is selected to alert clinicians that this early carcinoma has features of carcinoma in situ, but still carries a potential for metastasis.
子宫浆液性乳头状癌(UPSC)是一种生物学行为侵袭性很强的癌症,因其临床预后不佳,导致子宫内膜癌死亡人数不成比例。尽管UPSC的前驱病变在形态学和分子学方面均已被提出,但诊断对手术病理学家来说仍然是一项挑战,尤其是在活检标本中,很大程度上是因为它有多种组织学模式以及许多良性形态学上的相似病变。在本研究中,我们使用p53免疫组化染色作为辅助检测方法,前瞻性地正确识别了6例子宫表面癌(USC),回顾性地识别了3例。当p53过表达的截断分数为7或更高时,这种免疫染色方法的敏感性和特异性均接近100%。通过接受操作特征曲线估计的精确度为100%,表明p53过表达分数的诊断价值非常高。p53免疫组化染色被认为是UPSC可能的前驱病变的一种重要辅助诊断方法。UPSC可能的前驱病变,以前称为子宫内膜上皮内癌或原位子宫内膜癌,似乎代表了UPSC的早期阶段。然而,与其名称所暗示的不同,这种病变往往是多中心的,并且比普通原位癌的行为更具侵袭性。因此,我们更喜欢使用子宫表面癌这个术语,它更具描述性且限制较少,以强调UPSC前驱病变独特的侵袭性本质。我们假设使用子宫表面癌这个术语而非子宫内膜上皮内癌或原位子宫内膜癌的原因是,后两个术语似乎定义了一个局限于子宫内膜上皮的肿瘤过程,没有转移的可能性。实际上,UPSC的前驱病变有累及间质和血管间隙的倾向,正如在一例前瞻性识别的USC病例中所见的间质和血管浸润。因此,选择子宫表面癌这个术语是为了提醒临床医生,这种早期癌具有原位癌的特征,但仍有转移的可能性。